Back to 
HighTower Advisors, LLC
HighTower Advisors, LLC
BTAIQ5 quarters
Position history for HighTower Advisors, LLC's holdings in BioXcel Therapeutics, Inc.
Yes. HighTower Advisors holds 41,000 shares of BTAIQ (BioXcel Therapeutics), worth $57,810, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. HighTower Advisors has held BTAIQ since Q2 2025, across 5 quarterly 13F filings.
Current Value
$57,810
Current Shares
41,000
Total Value Change
+$13,284
Total Shares Change
+16,400
Quarter-by-Quarter History
Other major holders of BTAIQ: MILLENNIUM MANAGEMENT LLC, OAKTREE CAPITAL MANAGEMENT LP